Investment Memo: RENUKA

[s2If !current_user_can(access_s2member_level1)][lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

Our Rating: HOLD

Mehabe score: 3
G Factor: 5
Piotski Score: 7
The stock has a rating HOLD. The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 5 and Piotski score of 7.

Description

Shree Renuka Sugars Limited is an agri-business and bio-energy company. The Company is engaged in the business of sugar manufacturing, sugar refining, sugar trading, ethanol and co-generation.Site: RENUKA

Market Cap: Rs 7,248 cr Price: 34.0 Trading pe: x
Book-value: -2.81/share Div yield: 0.00 % Earning yield: 2.60%
Face-value: 1.00/share 52week high: 32.45 52week low: 8.05

Technical Analysis

  • Stock trades at 34.0, above its 50dma 18.75. It also trades above its 200dma 12.82. The stock remains bullish on techicals
  • The 52 week high is at 32.45 and the 52week low is at 8.05

Price Chart

P/E Chart

Sales and Margin

Strengths

Weakness

– has low interest coverage ratio.
-The company has delivered a poor sales growth of -10.52% over past five years.

Competition

– The industry trades at a mean P/E of 15.3x. Bannari Amm.Sug. trades at the industry’s max P/E of 24.77x. RENUKA trades at a P/E of x
– Industry’s mean G-Factor is 3.6 while the mean Piotski score is 8.0. RENUKA has a G-Factor of 5 and Piotski scoreof 7.
– Average 1 month return for industry is 30.7%. The max 1- month return was given by Sh.Renuka Sugar: a return of 106.36 %

Quarterly Results

  • Sales for period ended Mar 2021 is Rs 1320.0 cr compared to Rs 1432.0 cr for period ended Mar 2020, a fall of 7.8%
  • Operating Profits reported at Rs 250.0 cr for period ended Mar 2021 vis-vis 66.0 for period ended Mar 2020 .
  • Operating Margins expanded 1433.0 bps for period ended Mar 2021 vis-vis Mar 2020 .
  • The EPS for Mar 2021 was Rs -0.21 compared to Rs -0.66 for previous quarter ended Dec 2020 and Rs -0.76 for Mar 2020

Profit & Loss Statement

Profit&Loss Comments

  • Company reported sales of Rs 5648.0 cr for period ended Mar 2021 vis-vis sales of Rs 4876.0 cr for the period ended Mar 2020, a healthy growth of 13.7%. The 3 year sales cagr stood at -3.3%.
  • Net Profit reported at Rs -115.0 cr for period ended Mar 2021 vis-vis sales of Rs 2099.0 cr for the period ended Mar 2020, falling 0%.

Balance Sheet Statement

Cash Flow Statement

Cash Flow comments

    Sales Growth

    Profit Growth Statement

    Profit Growth Statement

    Stock Price CAGR

    Return of Equity

    General Comments

    – The stock has given a return of 235% on a 1 Year basis vis-vis a return of 39% over the last 3 Years.
    – The compounded sales growth on a TTM bassis is 16% vis-vis a compounded sales growth of -3% over the last 3 Years.
    – The compounded profit growth on a TTM basis is -105% vis-vis a compounded profit growth of 25% over the last 3 Years.

    Ratios

    Shareholding Pattern

    – FII shareholding has remained largely constant. The Mar 2021 fii holding stood at 1.42% vis-vis 1.39% for Dec 2020
    – Public shareholding has risen for the period ended Mar 2021. The Mar 2021 public holding stood at 17.83% vis-vis 15.15% for Dec 2020

    Conclusion

    – – has low interest coverage ratio.
    -The company has delivered a poor sales growth of -10.52% over past five years.

    • The business fundamentals of the stock remain stable. Stronger near term results will build interest in the stock. We suggest to wait for a upturn in business performance.
    • Technically, the stock remains above its 50 DMA 18.75 and is trading at 34.0, thus bullish price action wise.
    • Thus, overall we retain a HOLD on the stock.

    [/s2If]
    Join Our Telegram Group